FMP
Merck Shares Plunge 8% as Weak Guidance Overshadows Strong Revenue Growth
Feb 4, 2025 2:33 PM - Davit Kirakosyan
Image credit: FMP
Merck & Co (NYSE:MRK) saw its stock sink over 8% in pre-market today after delivering mixed fourth-quarter results, with earnings missing expectations, revenue exceeding forecasts, and full-year guidance coming in below analyst estimates.
For Q4, the pharmaceutical giant reported adjusted earnings per share (EPS) of $1.72, falling short of the $1.81 consensus estimate. However, revenue climbed 7% year-over-year to $15.6 billion, surpassing projections of $15.47 billion. Excluding foreign exchange impacts, revenue rose 9%.
Merck's 2025 outlook disappointed investors, with adjusted EPS guidance of $8.88 to $9.03, below Wall Street’s forecast of $9.21. The company also anticipates full-year revenue between $64.1 billion and $65.6 billion, missing the consensus estimate of $67.36 billion.
For the full year 2024, Merck posted $64.2 billion in worldwide sales, reflecting 7% annual growth—or 10% on a constant currency basis. The company’s flagship cancer treatment, KEYTRUDA, remained a key driver, with sales surging 18% to $29.5 billion.
Other Blogs
May 27, 2024 3:30 PM - Rajnish Katharotiya
The best 5 GPU stocks other than NVDA
In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...
Jun 6, 2024 2:47 AM - Parth Sanghvi
ROE vs ROA: Which Metric is More Important for Investors?
ROE vs. ROA: Which Metric is More Important for Investors? When evaluating a company's financial performance, investors often rely on various metrics to gauge profitability and efficiency. Two commonly discussed metrics are Return on Equity (ROE) and Return on Assets (ROA). Understanding the diff...
Jun 6, 2024 2:57 AM - Parth Sanghvi
DCF vs NPV: Which Valuation Method Should You Use?
When it comes to valuing an investment or a business, two of the most commonly used methods are Discounted Cash Flow (DCF) and Net Present Value (NPV). Both methods are essential tools in finance, but they serve slightly different purposes and are used in different contexts. This guide will explore ...
